Prostate cancer decisions — 2022

The Veteran withdrew his appeal for an increased rating for status post prostate cancer, and the matter is dismissed.

The Board has remanded the case due to new evidence submitted by the Veteran. The issue of service connection for prostate cancer will be reconsidered with this additional information.

The Board has remanded the claims of an increased rating for PTSD, prostate cancer, and hearing loss due to incomplete consideration of evidence and need for clarification regarding active disease status.

The Board has granted service connection for larynx cancer and prostate cancer with residuals of voiding dysfunction, both presumed to be due to herbicide exposure during the Veteran's service in Thailand.

The Board has remanded the claims for diabetes mellitus, colon cancer, prostate cancer, and ischemic heart disease due to potential exposure to contaminated water at Camp Lejeune. The Veteran's claim will be further evaluated with a medical opinion regarding the relationship between his service and these conditions.

The Board has decided that the claim for a rating reduction from 100 percent to 40 percent for residuals of prostate cancer with bilateral gynecomastia is moot because it was previously adjudicated in December 2020.

The Veteran's claims for prostate cancer and type II diabetes mellitus (DM) have been reopened due to the submission of new and material evidence. The effective date for a 10 percent evaluation for bilateral hearing loss is denied.,The Veteran's bladder condition, hypertension, erectile dysfunction (ED), headaches, and cause of death are all remanded for further development.

The Board has reopened the claim of service connection for the cause of the Veteran's death due to new evidence linking his major depressive disorder to his death. The Board granted service connection, assigning a 100% rating.

The Board has decided to remand the case due to a need for a new medical opinion regarding whether the Veteran's prostate cancer, coronary artery disease, or hypertension contributed to his death.

The Board has remanded the Veteran's claims for increased ratings and SMC due to incomplete medical opinions regarding his prostate cancer residuals and fecal incontinence. The claims will be reviewed based on the available evidence of record.

The Board has remanded the Veteran's claims for type II diabetes mellitus, prostate cancer, incontinence, and erectile dysfunction due to inadequate examinations that did not consider his reports of service exposure.

The Veteran's residuals of prostate cancer were manifested by voiding dysfunction with daytime voiding interval between two and three hours and awakening to void two times per night from January 1, 2015 to April 17, 2017. A rating in excess of 10 percent was denied.

The Board has remanded the claims of service connection for diabetes mellitus, Type II, prostate cancer, urinary bladder cancer, and erectile dysfunction (ED) as secondary to exposure to Agent Orange due to new evidence added since the March 2020 SOC.

The Veteran's service connection claims for ischemic heart disease, prostate cancer, and erectile dysfunction due to herbicide exposure are granted. The Board found that the Veteran was exposed to herbicides during his service in Thailand and established presumptive service connection for these conditions.

The Veteran's appeal for service connection for depression has been dismissed. Service connection for bilateral hearing loss, tinnitus, and gastroesophageal reflux disease (GERD) have been granted. The remaining issues are being remanded due to lack of a current diagnosis or treatment.

The Veteran's appeal for service connection for prostate cancer with residuals has been dismissed due to his death.

The Board denied the claim for service connection of prostate cancer, finding that there is no causal relationship between the current diagnosis and in-service symptom.

The Board has restored service connection for prostate cancer and erectile dysfunction as secondary to service-connected prostate cancer, finding that the severance of these conditions was improper due to lack of clear and unmistakable error.

The Veteran's attorney withdrew the appeals for prostate cancer and coronary artery disease, leading to their dismissal.

The Veteran's prostate cancer was not service connected as it is presumed to be due to herbicide exposure aboard the USS Mahan. However, there is no evidence that the Veteran served in an area where herbicides were used during his time on the ship.